← Browse by Condition
Medical Condition

nk t cell lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05833893 Phase 2
Recruiting

Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

Enrollment
10 pts
Location
China
Sponsor
Chinese PLA General Hospital
View Trial →